The efficacy of coronary sinus reducer in patients with refractory angina —A systematic review of the literature

ConclusionsThe CS reducer is a promising treatment option for patients with refractory angina who are not candidates for revascularization. However, larger randomized control trials with long ‐term follow‐up are needed to elucidate its role.

Source: Journal of Interventional Cardiology - December 5, 2018 Category: Cardiology Authors: George Bazoukis, Emmanouil S. Brilakis, Gary Tse, Konstantinos P. Letsas, Panagiotis Kitsoulis, Tong Liu, Adrian Baranchuk, Antonios Sideris, Costas Tsioufis, Stavros Stavrakis Tags: REVIEW ARTICLE Source Type: research